查脂质代谢相关基因作为慢性阻塞性肺部疾病的诊断指标
Chen Jiang1,2, Meijuan Peng1,2, Ziyu Dai1,2
1Department of Geriatrics, Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China.
International journal of chronic obstructive pulmonary disease
|December 4, 2023
概括
这项研究确定BCHE和PLA2G7是参与慢性阻塞性肺病 (COPD) 的关键脂质代谢基因. 这些基因表现出改变的表达,可以作为COPD诊断和治疗的新生物标志物.
科学领域:
- 生物化学和分子生物学
- 肺部病理学 肺部病理学
- 基因组学就是基因组学.
背景情况:
- 慢性阻塞性肺病 (COPD) 与脂质代谢失调有关,但潜在的机制尚不清楚.
- 识别COPD相关脂质代谢中的特定分子参与者对于理解疾病发病过程至关重要.
研究的目的:
- 在COPD中识别差异表达的脂质代谢相关基因 (DeLMRGs).
- 通过生物信息分析发现COPD潜在的诊断和治疗生物标志物.
主要方法:
- 下载并分析了COPD mRNA微阵列数据集 (GSE76925),以识别差异表达基因 (DEG).
- 与脂质代谢相关基因 (LMRGs) 交叉DEG,以找到DeLMRGs.
- 利用生物信息工具进行途径分析,构建蛋白质-蛋白质相互作用网络,并使用单独的数据集 (GSE8581) 和ELISA进行验证.
主要成果:
- 确定了20个DeLMRG,其中1个是上调监管的,19个是下调监管的.
- 选了10个枢纽基因,包括BCHE (下调) 和PLA2G7 (上调).
- 在COPD数据集和细胞模型中验证了BCHE和PLA2G7的差异表达.
结论:
- 在COPD中,BCHE和PLA2G7被确定为重要的,差异表达的脂质代谢相关基因.
- 这些基因代表了COPD诊断和潜在治疗点的有希望的新生物标志物.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Overview of Lipid Metabolism
1.6K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
COPD: Pathogenesis and Clinical Features
292
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
292


